Rock Springs Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-365,000
Closed -$25.9M 146
2018
Q2
$25.9M Buy
365,000
+51,600
+16% +$3.64M 1% 31
2018
Q1
$23.6M Hold
313,400
1.01% 32
2017
Q4
$22.5M Hold
313,400
1.02% 30
2017
Q3
$25.4M Hold
313,400
1.17% 25
2017
Q2
$22.2M Buy
313,400
+26,900
+9% +$1.79M 1.12% 28
2017
Q1
$19.5M Buy
286,500
+10,000
+4% +$703K 1.12% 30
2016
Q4
$19.8M Sell
276,500
-67,500
-20% -$5.02M 1.32% 24
2016
Q3
$27.2M Buy
344,000
+300
+0.1% +$24.4K 1.71% 17
2016
Q2
$28.7M Buy
343,700
+13,400
+4% +$1.19M 2.12% 10
2016
Q1
$30.3M Buy
330,300
+5,000
+2% +$451K 2.54% 8
2015
Q4
$32.9M Buy
325,300
+67,800
+26% +$7.05M 2.49% 6
2015
Q3
$25.3M Hold
257,500
2.05% 9
2015
Q2
$30.1M Buy
257,500
+2,500
+1% +$273K 2.2% 9
2015
Q1
$25M Hold
255,000
2.34% 10
2014
Q4
$24M Sell
255,000
-108,000
-30% -$11.2M 2.81% 8
2014
Q3
$38.6M Buy
363,000
+23,000
+7% +$2.25M 5.98% 1
2014
Q2
$28.2M Buy
340,000
+9,000
+3% +$701K 5.05% 1
2014
Q1
$23.5M Buy
331,000
+46,000
+16% +$3.61M 5.41% 2
2013
Q4
$21.4M Buy
+285,000
New +$19.8M 7.65% 1

Other funds holding GILD

Rock Springs Capital Management's GILD Position: Q3 2018 in Review

Rock Springs Capital Management sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 365,000 shares — an estimated $25.9M sold.

Rock Springs Capital Management first reported a position in GILD in Q4 2013 and held it in 19 quarters. The position peaked at $38.6M in Q3 2014. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Rock Springs Capital Management reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
  • Rock Springs Capital Management sold 365,000 Gilead Sciences shares in Q3 2018, an estimated $25.9M.
  • Rock Springs Capital Management first reported a position in Gilead Sciences in Q4 2013 and held it in 19 quarters.
  • Rock Springs Capital Management's Gilead Sciences position peaked at $38.6M in Q3 2014.
  • 1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Rock Springs Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.